PEDIATRICS Vol. 106 No. 1 July 2000, p. e13
ELECTRONIC ARTICLE:
An Unusual Presentation of Doxycycline-Induced Photosensitivity
,
From the Divisions of * Biochemical Diseases and
Dermatology,
Department of Pediatrics, British Columbia's Children's Hospital,
University of British Columbia, Vancouver, British Columbia, Canada.
| |
ABSTRACT |
|---|
|
|
|---|
Photoonycholysis in association with a generalized phototoxic reaction or as an isolated event is a well-recognized complication of the tetracycline group of antibiotics. We describe a 14-year-old white girl with cystic fibrosis who developed photoonycholysis of all 20 nails while receiving treatment with doxycycline. Pediatricians who prescribe tetracyclines should be aware of this potential complication.
Key words: doxycycline, cystic fibrosis, photosensitivity, onycholysis, vitamin E, antioxidants.
Photosensitivity is a well-recognized complication of the
tetracycline group of antibiotics.1-3 Nail involvement is
characterized by photoonycholysis and may occur in association with a
generalized phototoxic reaction or, less commonly, as an isolated
event.4-6 This has rarely been reported in pediatric
patients.7 We report a teenage girl with cystic fibrosis
who developed painful subungual hemorrhage while being treated with
doxycycline.
A 14-year-old white girl with cystic fibrosis was seen for
evaluation of painful, discolored fingernails and toenails. Two weeks
earlier, she was hospitalized with an acute deterioration in
respiratory function. Sputum cultures were positive for
Pseudomonas aeruginosa, Stenotrophomonas
maltophilia, and Burkholderea cepacia, and she was
treated with intravenous tobramycin and penicillin. S
maltophilia and B cepacia were sensitive to
doxycycline. She was discharged from the hospital on doxycycline (100 mg twice daily). The patient and mother were aware of
tetracycline-induced photosensitivity and a chemical sunscreen with sun
protection factor 45 was applied to all exposed areas of skin. Four
days later, after spending time sunbathing, she complained of
discomfort on the tips of her toes. This progressed to a throbbing pain
that was unrelieved by 500 mg of acetaminophen. Within 3 days, the discomfort had spread to involve her fingernails. Nine days after the
onset of symptoms a pinkish purple discoloration developed on the
toenails. This darkened to a purple-black color and the fingernails
became involved as well. The throbbing pain subsided as the
discoloration progressed.
On physical examination, there was a purplish black subungual
discoloration of the thumbnails and several toenails. There was
violaceous erythema of the remaining nail beds (Fig
1). The nail plates showed no evidence of
trauma or onycholysis. There was minimal residual tenderness. Mild
clubbing was observed. The remainder of the cutaneous examination
revealed only slight facial erythema.
![]()
CASE REPORT

View larger version (101K):
[in a new window]
Fig. 1.
Purplish black discoloration of the thumbnails and erythema of the
fingernail beds.
Doxycycline was discontinued after 17 days of treatment. The nail changes resolved spontaneously within the following 4 weeks. Onycholysis was not observed during this period. However, 4 months later, distal onycholysis was observed on the thumbnails and great toenails (Fig 2). Beau's lines were observed on all nails.
|
| |
DISCUSSION |
|---|
|
|
|---|
The incidence of phototoxic cutaneous reactions to doxycycline is reported to be <5%. A study of 106 acne patients found a much higher incidence (35.8%) and suggested that the phenomenon is dose-related5; 20% of patients taking 150 mg/day of doxycycline developed a light-sensitive rash, whereas 42% of those taking 200 mg/day were affected. One of these patients had painful photoonycholysis.
Photoonycholysis refers to separation of the nail plate from the nail bed after exposure to ultraviolet light. Drug-induced photoonycholysis is seen most commonly with the second-generation tetracyclines, doxycycline and demeclocycline.6-8 It may also occur with other tetracyclines and with psoralens and fluoroquinolones.1 Pain in the nail bed or tips of the fingers and toes is often the first symptom with subsequent progression to subungual erythema, subungual hemorrhage, and onycholysis.4,8 Pain and subungual erythema are infrequently the only manifestations at the time of presentation. Onycholysis develops after a variable period. Pain and tenderness seem to decrease as the nail changes become clinically evident. Three separate patterns of onycholysis have been described.8
It is suggested that patients with skin types 1 and 2 may be more susceptible to doxycycline photosensitivity than patients with darker skin pigmentation.9 Both ultraviolet A and ultraviolet B radiation have been implicated.10 The mechanism of the phototoxic reaction has not been fully elucidated. It is believed to be mediated by excited-state singlet oxygen and free radicals after irradiation with ultraviolet A radiation, thereby causing selective injury to mitochondria, within which doxycycline and other tetracyclines are localized.11
Antioxidant status may affect the degree of vulnerability to phototoxicity.12,13 It is generally believed that cystic fibrosis patients may have low antioxidant status and, therefore, may be more vulnerable to damage by this mechanism.14 It has been observed that cystic fibrosis patients have a high incidence of ciprofloxacin (quinolone)-induced phototoxicity.15 A vitamin E level measured in our patient was 11.8 µmol/L (13.0-24). She was prescribed a vitamin E supplement.
A number of possible explanations for why the nails should be a site of predilection for phototoxic damage in some patients have been proposed. Irradiation with 313- to 500-nm wavelengths (3%-20%) can penetrate a .7-mm fingernail plate.8 The nail acts as a convex lens, which may enhance and concentrate ultraviolet penetration. There is less melanin and, therefore, less ultraviolet protection in the nail beds than in other sites. It is also possible that application of chemical sunscreen may afford sufficient photoprotection for exposed areas of skin while leaving the nail bed unprotected. The cause of the intense pain during the early stages of the process is unclear but may be related to vasodilation of the nail bed capillaries.
As a differential diagnosis, trauma was excluded because this could not occur symmetrically on all 20 nail beds without evidence of nail damage. The clinical presentation of subungal hemorrhage on all 20 nail beds would not be consistent with a fixed drug eruption, which occurs as circumscribed round to oval patches with erythema in localized areas. Hemorrhagic lesions secondary to raised intravascular pressure from coughing usually lead to petechiae and not subungal erythema and hemorrhage.
With renewed interest in the use of tetracyclines and their second-generation derivatives for the treatment and prophylaxis of specific infectious diseases, it is important for physicians and pediatricians to be aware of potential photosensitivity. This may be more common in cystic fibrosis patients or others with compromised antioxidant status. Rarely, as in our patient, pain and discoloration of the nail beds may be the sole manifestation of phototoxicity. Fair-skinned patients who are prescribed doxycycline during the summer months should be advised to avoid sun exposure. Reassurance may be given that the complication is not dangerous but potentially painful.
| |
FOOTNOTES |
|---|
Received for publication Aug 19, 1999; accepted Feb 2, 2000.
Reprint requests to (A.G.F.D.) Room 2C66, Division of Biochemical Diseases, British Columbia's Children's Hospital, 4480 Oak St, British Columbia, Vancouver, Canada, V6H 3V4. E-mail: gdavidson{at}cw.bc.ca
| |
REFERENCES |
|---|
|
|
|---|
- Kapusnik-Uner JE, Sande MA, Chambers HF. Tetracyclines, chloramphenicol, erythromycin and miscellaneous antibacterial agents. In: The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill Companies, Inc; 1996:1123-1153
-
Joshi N,
Miller DQ
Doxycycline revisited.
Arch Intern Med
1997;
157:1421-1428
[Abstract/Free Full Text] - Edwards R Doxycycline and photosensitivity. N Z Med J 1987; 100:640 [Medline]
- Segal BM Photosensitivity, nail discoloration and onycholysis. Arch Intern Med 1963; 112:63-65
-
Layton AM,
Cunliffe WJ
Phototoxic eruptions due to doxycycline
a dose related phenomenon.
Clin Exp Dermatol
1993;
18:425-427 [CrossRef][Medline] - Maibach H Second generation tetracyclines: a dermatologic overview. Cutis 1991; 48:411-417 [Medline]
- Coffin SE, Puck J Painful discoloration of the fingernails in a 15-year-old boy. Pediatr Infect Dis J 1993; 12:702-706 [CrossRef][Medline]
- Baran R, Juhlin L Drug induced photo-onycholysis. J Am Acad Dermatol 1987; 17:1013-1016
- Smith EL, al Raddadi A, al Ghamdi F, Kutbi S Tetracycline phototoxicity. Br J Dermatol 1995; 132:316-317 [Medline]
- Bjellerup M, Ljunggren B Differences in phototoxic potency should be considered when tetracyclines are prescribed during summertime: a study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema. Br J Dermatol 1994; 130:356-360 [CrossRef][Medline]
- Shea CR, Olack GA, Morrison H, Chen N, Hasan T Phototoxicity of lumidoxycycline. J Invest Dermatol 1993; 101:329-333 [CrossRef][Medline]
- Darr D, Dunston S, Faust H, Pinnell S Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as photoprotectants. Acta Derm Venereol 1996; 76:264-268 [Medline]
- Lopez-Torres M, Thiele JJ, Shindo Y, Han D, Packer L Topical application of alpha-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. Br J Dermatol 1998; 138:207-215 [CrossRef][Medline]
- Dominquez C, Gartner S, Linan S, Cobos N, Moreno A Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998; 8:149-153 [Medline]
- Peacock D, Wong LTK, Davidson AGF Photosensitivity due to ciprofloxacin in children with cystic fibrosis. Israel J Med Sci 1996; 32:S170
Pediatrics (ISSN 0031 4005). Copyright ©2000 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
S. Salhan, V. Tripathi, R. Sehgal, G. Kumar, G. P. Talwar, and A. Chatterjee A Phase II Randomized Controlled Trial to Evaluate the Safety and Efficacy of Praneem Polyherbal Vaginal Tablets Compared With Betadine Vaginal Pessary in Women With Symptoms of Abnormal Vaginal Discharge Asia Pac J Public Health, October 1, 2009; 21(4): 461 - 468. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






